Biomarin Pharmaceutical (BMRN) Change in Intangibles (2017 - 2019)

Biomarin Pharmaceutical's Change in Intangibles history runs 3 years deep, the most recent figure standing at $10.0 million for Q4 2019.

• Quarterly Change in Intangibles fell 66.67% year-over-year to $10.0 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $55.0 million (down 64.52% YoY) and the FY2019 annual result came in at $25.0 million, down 50.0% from the prior year.
• Change in Intangibles was $10.0 million for Q4 2019 at Biomarin Pharmaceutical, down from $15.0 million in the prior quarter.
• Across five years, Change in Intangibles topped out at $125.0 million in Q4 2017 and bottomed at $10.0 million in Q4 2019.
• A 3-year average of $45.0 million and a median of $22.5 million in 2018 frame the typical range for Change in Intangibles.
• Annual changes were most pronounced in 2018 — Change in Intangibles tumbled 76.0% — and 2019, when it sank 66.67%.
• Biomarin Pharmaceutical's Change in Intangibles stood at $125.0 million in 2017, then tumbled by 76.0% to $30.0 million in 2018, then plunged by 66.67% to $10.0 million in 2019.
• Business Quant data shows BMRN's Change in Intangibles at $10.0 million in Q4 2019, $15.0 million in Q3 2019, and $30.0 million in Q4 2018.